Factors influencing participation in colorectal cancer screening programs in Spain

Empreu sempre aquest identificador per citar o enllaçar aquest ítem http://hdl.handle.net/10045/69448
Información del item - Informació de l'item - Item information
Títol: Factors influencing participation in colorectal cancer screening programs in Spain
Autors: Vanaclocha-Espi, Mercedes | Ibáñez, Josefa | Molina-Barceló, Ana | Pérez, Elena | Nolasco, Andreu | Font, Rebeca | Pérez-Riquelme, Francisco | Vega, Mariola de la | Arana-Arri, Eunate | Oceja, M. Elena | Espinàs, Josep Alfons | Portillo, Isabel | Salas, Dolores | CRIBEA Group
Grups d'investigació o GITE: Grupo Balmis de Investigación en Salud Comunitaria e Historia de la Ciencia
Centre, Departament o Servei: Universidad de Alicante. Departamento de Enfermería Comunitaria, Medicina Preventiva y Salud Pública e Historia de la Ciencia
Paraules clau: CCR screening | FOBT | Participation
Àrees de coneixement: Enfermería
Data de publicació: 5-de setembre-2017
Editor: Elsevier
Citació bibliogràfica: Preventive Medicine. 2017. doi:10.1016/j.ypmed.2017.08.019
Resum: To analyze the sociodemographic and organizational factors influencing participation in population-based colorectal cancer screening programs (CRCSP) in Spain, a retrospective study was conducted in a cohort of people invited to participate in the first 3 screening rounds of 6 CRCSP from 2000 to 2012. Mixed logistic regression models were used to analyze the relationship between sociodemographic and organizational factors, such as the type of fecal occult blood test (FOBT) used and the FOBT delivery type. The analysis was performed separately in groups (Initial screening-first invitation, Subsequent invitation for previous never-responders, Subsequent invitation-regular, Subsequent invitation-irregular intervals). The results showed that, in the Initial screening-first invitation group, participation was higher in women than in men in all age groups (OR 1.05 in persons aged 50–59 years and OR 1.12 in those aged 60–69 years). Participation was also higher when no action was required to receive the FOBT kit, independently of the type of screening (Initial screening-first invitation [OR 2.24], Subsequent invitation for previous never-responders [OR 2.14], Subsequent invitation-regular [OR 2.03], Subsequent invitation-irregular intervals [OR 9.38]) and when quantitative rather than qualitative immunological FOBT (FIT) was offered (Initial screening-first invitation [OR 0.70], Subsequent invitation for previous never-responders [OR 0.12], Subsequent invitation-regular [OR 0.20]) or guaiac testing (Initial screening-first invitation [OR 0.81], Subsequent invitation for previous never-responders [OR 0.88], Subsequent invitation-regular [OR 0.73]). In conclusion, the results of this study show that screening participation could be enhanced by inclusion of the FOBT kit with the screening invitation and the use of the quantitative FIT.
Patrocinadors: This Project was funded by the Fondo de Investigación Sanitario with cofunding from FEDER [PI12/00944]
URI: http://hdl.handle.net/10045/69448
ISSN: 0091-7435 (Print) | 1096-0260 (Online)
DOI: 10.1016/j.ypmed.2017.08.019
Idioma: eng
Tipus: info:eu-repo/semantics/article
Drets: © 2017 Elsevier Inc.
Revisió científica: si
Versió de l'editor: http://dx.doi.org/10.1016/j.ypmed.2017.08.019
Apareix a la col·lecció: INV - SALUD - Artículos de Revistas

Arxius per aquest ítem:
Arxius per aquest ítem:
Arxiu Descripció Tamany Format  
Thumbnail2017_Vanaclocha-Espi_etal_PreventiveMed_accepted.pdfAccepted Manuscript (acceso abierto)716,9 kBAdobe PDFObrir Vista prèvia
Thumbnail2017_Vanaclocha-Espi_etal_PreventiveMed_final.pdfVersión final (acceso restringido)165,32 kBAdobe PDFObrir     Sol·licitar una còpia


Tots els documents dipositats a RUA estan protegits per drets d'autors. Alguns drets reservats.